세계의 트로포닌 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Troponin was estimated to be worth US$ 1690 million in 2024 and is forecast to a readjusted size of US$ 3006 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Troponin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Troponin, or the troponin complex, is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not smooth muscle. Discussions of troponin often pertain to its functional characteristics and/or to its usefulness as a diagnostic marker or therapeutic target for various heart disorders in particular as a highly specific marker for myocardial infarction or heart muscle cell death. A troponin test measures the levels troponin T or troponin I proteins in the blood. These proteins are released when the heart muscle has been damaged, such as occurs with a heart attack.In this report, we study the troponin assay kit.

The troponin market is primarily driven by the growing global burden of cardiovascular diseases (CVDs), especially acute myocardial infarction (AMI), commonly known as heart attacks. Troponin, a cardiac biomarker released into the bloodstream during heart muscle injury, is considered the gold standard for diagnosing AMI. With the rise in aging populations, sedentary lifestyles, and associated risk factors such as diabetes, obesity, and hypertension, the demand for accurate and early cardiac diagnostics has surged. Hospitals and emergency care centers increasingly rely on high-sensitivity troponin assays (hs-cTn) for rapid detection and risk stratification of patients presenting with chest pain. Moreover, advancements in point-of-care testing (POCT) technologies have enabled faster turnaround times and easier troponin testing outside centralized labs, such as in ambulances, clinics, or rural settings. Government efforts to reduce cardiac-related mortality, as well as growing awareness about the importance of early diagnosis, continue to support the expansion of the troponin testing market.

Despite strong demand, the troponin market faces several challenges that can impact its growth trajectory. One major issue is assay standardization-different diagnostic platforms may yield varying troponin levels due to differences in assay sensitivity, calibration, and reference ranges. This lack of uniformity can lead to inconsistencies in diagnosis and clinical decision-making. In low- and middle-income countries, limited access to high-sensitivity testing equipment, skilled personnel, and reliable healthcare infrastructure hinders widespread adoption. Additionally, while high-sensitivity troponin tests improve early detection, they may also detect clinically insignificant elevations, leading to overdiagnosis or false positives, which can result in unnecessary interventions and increased healthcare costs. Reimbursement and regulatory hurdles, particularly for newer POCT solutions, further constrain market penetration in certain regions. Lastly, competition among diagnostic companies and pricing pressure from healthcare systems and procurement agencies can challenge the profitability of troponin test manufacturers.

This report aims to provide a comprehensive presentation of the global market for Troponin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Troponin by region & country, by Type, and by Application.

The Troponin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Troponin.

Market Segmentation

By Company

• Abbott
• Roche
• Siemens Healthcare
• Beckman Coulter
• Biomerieux
• Mitsubishi
• Quidel
• Getein Biotech
• Improve Medical
• Response Biomedical

Segment by Type

• Troponin I (TnI)
• Troponin T (TnT)

Segment by Application

• Myocardial Infarction
• Acute Coronary Syndrome
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Troponin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Troponin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Troponin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Troponin Product Introduction
• 1.2 Global Troponin Market Size Forecast
  • 1.2.1 Global Troponin Sales Value (2020-2031)
  • 1.2.2 Global Troponin Sales Volume (2020-2031)
  • 1.2.3 Global Troponin Sales Price (2020-2031)
• 1.3 Troponin Market Trends & Drivers
  • 1.3.1 Troponin Industry Trends
  • 1.3.2 Troponin Market Drivers & Opportunity
  • 1.3.3 Troponin Market Challenges
  • 1.3.4 Troponin Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Troponin Players Revenue Ranking (2024)
• 2.2 Global Troponin Revenue by Company (2020-2025)
• 2.3 Global Troponin Players Sales Volume Ranking (2024)
• 2.4 Global Troponin Sales Volume by Company Players (2020-2025)
• 2.5 Global Troponin Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Troponin Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Troponin Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Troponin
• 2.9 Troponin Market Competitive Analysis
  • 2.9.1 Troponin Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Troponin Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Troponin as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Troponin I (TnI)
  • 3.1.2 Troponin T (TnT)
• 3.2 Global Troponin Sales Value by Type
  • 3.2.1 Global Troponin Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Troponin Sales Value, by Type (2020-2031)
  • 3.2.3 Global Troponin Sales Value, by Type (%) (2020-2031)
• 3.3 Global Troponin Sales Volume by Type
  • 3.3.1 Global Troponin Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Troponin Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Troponin Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Troponin Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Myocardial Infarction
  • 4.1.2 Acute Coronary Syndrome
  • 4.1.3 Others
• 4.2 Global Troponin Sales Value by Application
  • 4.2.1 Global Troponin Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Troponin Sales Value, by Application (2020-2031)
  • 4.2.3 Global Troponin Sales Value, by Application (%) (2020-2031)
• 4.3 Global Troponin Sales Volume by Application
  • 4.3.1 Global Troponin Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Troponin Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Troponin Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Troponin Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Troponin Sales Value by Region
  • 5.1.1 Global Troponin Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Troponin Sales Value by Region (2020-2025)
  • 5.1.3 Global Troponin Sales Value by Region (2026-2031)
  • 5.1.4 Global Troponin Sales Value by Region (%), (2020-2031)
• 5.2 Global Troponin Sales Volume by Region
  • 5.2.1 Global Troponin Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Troponin Sales Volume by Region (2020-2025)
  • 5.2.3 Global Troponin Sales Volume by Region (2026-2031)
  • 5.2.4 Global Troponin Sales Volume by Region (%), (2020-2031)
• 5.3 Global Troponin Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Troponin Sales Value, 2020-2031
  • 5.4.2 North America Troponin Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Troponin Sales Value, 2020-2031
  • 5.5.2 Europe Troponin Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Troponin Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Troponin Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Troponin Sales Value, 2020-2031
  • 5.7.2 South America Troponin Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Troponin Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Troponin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Troponin Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Troponin Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Troponin Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Troponin Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Troponin Sales Value, 2020-2031
  • 6.3.2 United States Troponin Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Troponin Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Troponin Sales Value, 2020-2031
  • 6.4.2 Europe Troponin Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Troponin Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Troponin Sales Value, 2020-2031
  • 6.5.2 China Troponin Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Troponin Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Troponin Sales Value, 2020-2031
  • 6.6.2 Japan Troponin Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Troponin Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Troponin Sales Value, 2020-2031
  • 6.7.2 South Korea Troponin Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Troponin Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Troponin Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Troponin Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Troponin Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Troponin Sales Value, 2020-2031
  • 6.9.2 India Troponin Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Troponin Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Abbott
  • 7.1.1 Abbott Company Information
  • 7.1.2 Abbott Introduction and Business Overview
  • 7.1.3 Abbott Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Abbott Troponin Product Offerings
  • 7.1.5 Abbott Recent Development
• 7.2 Roche
  • 7.2.1 Roche Company Information
  • 7.2.2 Roche Introduction and Business Overview
  • 7.2.3 Roche Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Roche Troponin Product Offerings
  • 7.2.5 Roche Recent Development
• 7.3 Siemens Healthcare
  • 7.3.1 Siemens Healthcare Company Information
  • 7.3.2 Siemens Healthcare Introduction and Business Overview
  • 7.3.3 Siemens Healthcare Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Siemens Healthcare Troponin Product Offerings
  • 7.3.5 Siemens Healthcare Recent Development
• 7.4 Beckman Coulter
  • 7.4.1 Beckman Coulter Company Information
  • 7.4.2 Beckman Coulter Introduction and Business Overview
  • 7.4.3 Beckman Coulter Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Beckman Coulter Troponin Product Offerings
  • 7.4.5 Beckman Coulter Recent Development
• 7.5 Biomerieux
  • 7.5.1 Biomerieux Company Information
  • 7.5.2 Biomerieux Introduction and Business Overview
  • 7.5.3 Biomerieux Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Biomerieux Troponin Product Offerings
  • 7.5.5 Biomerieux Recent Development
• 7.6 Mitsubishi
  • 7.6.1 Mitsubishi Company Information
  • 7.6.2 Mitsubishi Introduction and Business Overview
  • 7.6.3 Mitsubishi Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Mitsubishi Troponin Product Offerings
  • 7.6.5 Mitsubishi Recent Development
• 7.7 Quidel
  • 7.7.1 Quidel Company Information
  • 7.7.2 Quidel Introduction and Business Overview
  • 7.7.3 Quidel Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Quidel Troponin Product Offerings
  • 7.7.5 Quidel Recent Development
• 7.8 Getein Biotech
  • 7.8.1 Getein Biotech Company Information
  • 7.8.2 Getein Biotech Introduction and Business Overview
  • 7.8.3 Getein Biotech Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Getein Biotech Troponin Product Offerings
  • 7.8.5 Getein Biotech Recent Development
• 7.9 Improve Medical
  • 7.9.1 Improve Medical Company Information
  • 7.9.2 Improve Medical Introduction and Business Overview
  • 7.9.3 Improve Medical Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Improve Medical Troponin Product Offerings
  • 7.9.5 Improve Medical Recent Development
• 7.10 Response Biomedical
  • 7.10.1 Response Biomedical Company Information
  • 7.10.2 Response Biomedical Introduction and Business Overview
  • 7.10.3 Response Biomedical Troponin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Response Biomedical Troponin Product Offerings
  • 7.10.5 Response Biomedical Recent Development

8 Industry Chain Analysis

• 8.1 Troponin Industrial Chain
• 8.2 Troponin Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Troponin Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Troponin Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer